Barclays raised the firm’s price target on Humana (HUM) to $322 from $270 and keeps an Equal Weight rating on the shares. The firm revised up its “bull and bear” earnings estimates after assessing next year’s stars contract risk.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUM: